We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Exelixis and Boehringer Ingelheim Enter into Collaboration for Development of S1P1 Receptor Agonists

Companies establish an exclusive, worldwide collaboration with the aim to discover, develop and commercialize autoimmune disease therapies.
News

Cellexus and Groton Collaborate on Use of Automated Sampling with Single-Use Bioreactors

Collaboration uses Groton’s automated sampler with the Cellexus single-use bioreactors for aseptic sample extraction from cell culture.
News

Evotec Acquires Zebrafish Screening Operations of Summit Corporation

The acquisition against £ 0.5 million cash in 2009 expected to add approximately £ 1.5 million revenues in 2010.
News

Evotec to Re-engineer Drug Discovery and Development Operations

Evotec to concentrate all proprietary core research programs at its European operations.
News

Human Genome Sciences and Novozymes Announce Amendment to Albumin Fusion License Agreement

Both the companies gain right to exclusively license and/or sublicense a number of albumin fusion proteins in exchange for royalties and other consideration.
News

Maxygen Announces MAXY-G34 Licensing Arrangement with Cangene for Acute Radiation Syndrome

Cangene obtains an exclusive license to Maxygen’s MAXY-G34 protein therapeutic for an up-front fee of $500,000.
News

Tecan and Technoclone; a Collaboration for the University Children’s Hospital in Zurich

Collaboration to validate the TECHNOTHROMBIN® thrombin generation assay for Tecan’s Infinite® M200 multimode microplate reader.
News

Thermo Fisher Scientific Event Showcases New Breakthroughs in FAIMS

Attendees presented a number of breakthroughs enabled through their use of the FAIMS technology.
News

Roche NimbleGen CGH Microarrays Enable the First Maps of Genome-Wide DNA CNV in Dogs

Studies reveal that the extent of CNVs in the dog genome and their association with known and candidate disease genes is similar to mice and humans.
News

Agilent Technologies Completes Large-Scale Expansion of Nucleic Acid Manufacturing Capacity

Major expansion enables the company to manufacture several hundred kilograms of therapeutic oligonucleotides per year.
Advertisement